Alpha 2.0
Login Register
» Authors » Vinayaka Shahavi

Vinayaka Shahavi

Explore the profile of Vinayaka Shahavi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 16
Followers 0
Related Specialties
Hematology
General Medicine
Oncology
Top 10 Co-Authors
Akhilesh Sharma
Roshan Pawar
Dattatray Pawar
Vijay Ramanan
Riya Ballikar
Manoj Toshniwal
Sandip Shah
B Prashantha
Mukesh Jaiswal
Amol Dange
Published In
Indian J Hematol Blood Transfus
J Assoc Physicians India
Am J Sports Med
JCO Glob Oncol
Diabetes Res Clin Pract
Affiliations
Soon will be listed here.
Recent Articles
1.
Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial
Prabhash K, Deshmukh C, Malhotra H, Sharma A, Jain M, Dhamne N, et al.
JCO Glob Oncol . 2024 Nov; 10:e2400059. PMID: 39541562
Purpose: Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer, with approximately 225,419 new cases with over 125,000 deaths annually in India. This trial...
2.
Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB) Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study
Rana P, Deshmukh H, Shah U, Kumar V, Kanungo S, Singhal D, et al.
Clin Ophthalmol . 2024 Nov; 18:3071-3081. PMID: 39493839
Objective: This study aimed to compare efficacy, safety, and immunogenicity of the biosimilar ranibizumab in comparison with the Innovator Ranibizumab in treatment-naive patients with neovascular (wet) age-related macular degeneration (nAMD...
3.
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2...
Jain A, Vispute A, Dange A, Naskar A, Mondal A, Vivekanand B, et al.
Diabetes Ther . 2023 Nov; 15(1):215-227. PMID: 37957465
Introduction: The aim of the study was to evaluate the efficacy and safety of fixed-dose combination (FDC) of dapagliflozin (10 mg) and linagliptin (5 mg) in comparison to linagliptin 5 ...
4.
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Gupta P, Maheshwari S, Cherian J, Goni V, Sharma A, Tripathy S, et al.
Am J Sports Med . 2023 Jun; 51(9):2254-2266. PMID: 37366164
Background: Osteoarthritis is a chronic, progressive, and degenerative condition with limited therapy options. Recently, biologic therapies have been an evolving option for the management of osteoarthritis. Purpose: To assess whether...
5.
Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
Chandrakala S, Toshniwal M, Halvawala M, Padwal N, Sidharthan N, Malhotra P, et al.
Indian J Hematol Blood Transfus . 2023 Jun; 39(3):435-441. PMID: 37304488
Romiplostim is a Food and Drug Administration (FDA)-approved therapy for immune thrombocytopenia (ITP). Biosimilar is a biological product that has no clinical meaningful difference from an existing FDA-approved reference product....
6.
Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
Chandrakala S, Toshniwal M, Halvawala M, Padwal N, Sidharthan N, Malhotra P, et al.
Indian J Hematol Blood Transfus . 2023 Jun; 39(3):522-523. PMID: 37304472
[This corrects the article DOI: 10.1007/s12288-022-01602-5.].
7.
Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study
Ajmani A, Agrawal A, Prasad B, Basu I, Shembalkar J, Manikanth N, et al.
Diabetes Res Clin Pract . 2019 Sep; 157:107860. PMID: 31526825
Aim: This study aimed to assess efficacy and safety of evogliptin versus sitagliptin, when added to background metformin therapy in Indian patients with uncontrolled type 2 diabetes. Method: Overall, 184...
8.
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA Infection
Dube A, Deb A, Das C, Padhye D, Bhalla H, Basu I, et al.
J Assoc Physicians India . 2019 Jul; 66(12):47-50. PMID: 31313549
Background: Increasing resistance to currently available antimicrobials has led to the development of new agents. Arbekacin is aminoglycoside antibiotic currently used in Japan and Korea for the treatment of infections...